LANDOS BIOPHARMA INC's ticker is LABP and the CUSIP is 515069102. A total of 36 filers reported holding LANDOS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,151 | -86.1% | 23,995 | -76.7% | 0.00% | – |
| Q4 2022 | $51,555 | -52.3% | 103,089 | -38.1% | 0.00% | – |
| Q3 2022 | $108,000 | +16.1% | 166,608 | +30.6% | 0.00% | – |
| Q2 2022 | $93,000 | -60.3% | 127,555 | -19.8% | 0.00% | – |
| Q1 2022 | $234,000 | -84.0% | 159,001 | -47.8% | 0.00% | – |
| Q4 2021 | $1,463,000 | -67.1% | 304,798 | +0.0% | 0.00% | – |
| Q3 2021 | $4,450,000 | +26.3% | 304,794 | -0.1% | 0.00% | – |
| Q2 2021 | $3,524,000 | +94.2% | 305,185 | +61.9% | 0.00% | – |
| Q1 2021 | $1,815,000 | – | 188,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 1,827,478 | $2,696,000 | 2.05% |
| Perceptive Advisors | 14,869,915 | $21,933,000 | 0.44% |
| RTW INVESTMENTS, LP | 4,275,722 | $6,307,000 | 0.13% |
| ArchPoint Investors | 128,750 | $190,000 | 0.07% |
| Orbimed Advisors | 283,217 | $418,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,000 | $235,000 | 0.01% |
| Walleye Capital LLC | 93,533 | $138,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 158,875 | $234,000 | 0.00% |
| Renaissance Technologies | 340,500 | $502,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,324 | $3,000 | 0.00% |